Gene DX INC:1108521 [17-004167]
Ended Awarded Last action
- Contract number
- HHSN26100003
- Awardee
-
Genedx, LLC UEI H3J4SCC8F671 Part of Opko Health, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,300
Award facts
- Opportunity
-
- N02CP5261224 Solicitation number
- CLIA-certified clinical genetic testing for TP53 Award Notice · Posted Jun 23, 2015
- Contract value 100% obligated
- $6,300.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$638 | |
| Original award | $6,938 |
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to Genedx, LLC by National Cancer Institute (National Institutes of Health) on December 9, 2016.
How much is contract HHSN26100003 worth?
The government has obligated $6,300 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201500016I, an indefinite delivery contract.
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award